It also engages in the custom synthesis of advanced ..

The ability to produce large quantities of otherwise not commercially viable cannabinoids for select combination therapies that can be administered topically is quite possibly the most disruptive development yet witnessed in the still-young cannabinoid therapy space.

Thus, a company like InMed, with an attractive pipeline under development and proprietary biosynthesis technology it can exploit or even license out, is one for investors to keep an eye on.

high performance optical polymers ltd
Photo provided by Flickr

For example, bacteria or yeast-based systems are currently employed to make pharmaceuticals like biosynthesized insulin used daily by millions of diabetics worldwide.


halfon, eran; herbal synthesis ..

hadasit medical research services and development ltd
Photo provided by Flickr

The company’s breakthrough approach to cannabinoid biosynthesis has incredible potential in helping other companies with their cannabis-related drug development efforts.

Another company deeply invested in the manufacturing of synthetic (chemistry-based) cannabinoids is Zynerba Pharmaceuticals (NASDAQ: ZYNE).